İsmail Beypınar

17PUBLICATIONS

113CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)Haematological tumoursInnate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Jul 15, 2026

Real-World Treatment Outcomes After Nivolumab Progression in BRAF-Negative Metastatic Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group.

|Jun 26, 2026

Immunosuppressive Tumor Microenvironment Signatures Predict Early Progression in NSCLC Patients Receiving Immune Checkpoint Inhibitors: A Transcriptomic and Immune Deconvolution Analysis of GSE135222.

|May 27, 2026

Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h Infusions.

|May 07, 2026

Psoas muscle indices, visceral fat distribution, inflammatory markers and 90-day mortality in palliative medicine: retrospective cohort study.

|Mar 19, 2026

Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors.

Mustafa Gürbüz, Deniz Tural, Timuçin Çil

|Mar 04, 2026

Immune Checkpoint Inhibitors and Bone Health: Mechanisms, Clinical Implications, and Emerging Perspectives on Bone Fragility.

Muhammed Emin Bedir, Abdulhadi Cihangir Uguz, Ismail Beypinar

Pageof 3

Frequent Collaborators

Hacer Demir

Murat Araz

Semiha Urvay

Canan Yıldız

Berrak Mermit Ercek

Muslih Urun

Onur Yazdan Balçık

Meltem Baykara

Osman Köstek

Taner Korkmaz

Frequent Collaborators

Hacer Demir

Murat Araz

Semiha Urvay

Canan Yıldız